Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (301-310 of 456) with videos related to

Pageof 46
Sort By:
European Journal of Cancer|September 1, 1975
High dose intravenous bleomycin in the treatment of advanced lymphomasS P Hubbard, B A Chabner, G P Canellos, et al.
Cancer|August 1, 1978
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapyR C Young, G P Canellos, B A Chabner, et al.
Cancer|February 11, 1975
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapyP S Schein, B A Chabner, G P Canellos, et al.
Cancer|December 1, 1984
Cancer chemotherapy. Progress and expectations, 1984B A Chabner, R L Fine, C J Allegra, et al.
Lancet (London, England)|June 16, 1973
Maintenance chemotherapy for advanced Hodgkin's disease in remissionR C Young, G P Canellos, B A Chabner, et al.
Cancer Research|November 15, 1987
Adriamycin resistance in human tumor cells associated with marked alteration in the regulation of the hexose monophosphate shunt and its response to oxidant stressG C Yeh, S J Occhipinti, K H Cowan, et al.
Biochemical and Biophysical Research Communications|April 7, 1975
Stoichiometric inhibition of mammalian dihydrofolate reductase by the gamma-glutamyl metabolite of methotrexiate, 4-amino-4-deoxy-N-10-methylpteroylglutamyl-gamma-glutamateS A Jacobs, R H Adamson, B A Chabner, et al.
The Oncologist|August 20, 2002
Faith, identity, and leukemia: when blood products are not an optionKristine A Knuti, Philip C Amrein, Bruce A Chabner, et al.
The Oncologist|October 25, 2001
Complementary, alternative, integrative, or unconventional medicine?R T Penson, C M Castro, M V Seiden, et al.
Annals of Internal Medicine|October 1, 1977
Methotrexate and hemodialysisK R Hande, J E Balow, J C Drake, et al.
Pageof 46

Showing results (301-310 of 456) with videos related to

Sort By:
Pageof 46
European Journal of Cancer|September 1, 1975
High dose intravenous bleomycin in the treatment of advanced lymphomasS P Hubbard, B A Chabner, G P Canellos, et al.
Cancer|August 1, 1978
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapyR C Young, G P Canellos, B A Chabner, et al.
Cancer|February 11, 1975
Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapyP S Schein, B A Chabner, G P Canellos, et al.
Cancer|December 1, 1984
Cancer chemotherapy. Progress and expectations, 1984B A Chabner, R L Fine, C J Allegra, et al.
Lancet (London, England)|June 16, 1973
Maintenance chemotherapy for advanced Hodgkin's disease in remissionR C Young, G P Canellos, B A Chabner, et al.
Cancer Research|November 15, 1987
Adriamycin resistance in human tumor cells associated with marked alteration in the regulation of the hexose monophosphate shunt and its response to oxidant stressG C Yeh, S J Occhipinti, K H Cowan, et al.
Biochemical and Biophysical Research Communications|April 7, 1975
Stoichiometric inhibition of mammalian dihydrofolate reductase by the gamma-glutamyl metabolite of methotrexiate, 4-amino-4-deoxy-N-10-methylpteroylglutamyl-gamma-glutamateS A Jacobs, R H Adamson, B A Chabner, et al.
The Oncologist|August 20, 2002
Faith, identity, and leukemia: when blood products are not an optionKristine A Knuti, Philip C Amrein, Bruce A Chabner, et al.
The Oncologist|October 25, 2001
Complementary, alternative, integrative, or unconventional medicine?R T Penson, C M Castro, M V Seiden, et al.
Annals of Internal Medicine|October 1, 1977
Methotrexate and hemodialysisK R Hande, J E Balow, J C Drake, et al.
Pageof 46